Dementia
RecruitingEvaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older
Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older
- Disease:Dementia
- Substances:Recombinant Varicella Zoster Virus Glycoprotein E
Finland- Participants:65+ years · Healthy volunteers
- Substances:Recombinant Varicella Zoster Virus Glycoprotein E
- Sponsor:GlaxoSmithKline Biologicals
